Do people really think it doesn't matter that the results they announced, i.e. the percentages eradicated can't have been achieved with 22 people in each cohort? Unless they were treating fractions of people.
This sort of discrepancy is not trivial.
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-663
-
- There are more pages in this discussion • 338 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.3¢ |
Change
-0.008(2.03%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $998.1K | 2.760M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11865 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 468395 | 15 |
View Market Depth
| Last trade - 11.52am 19/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |